This is free case-based activity that includes discussion of a forty-four year old man presents with fatigue that has been worsening over 3 weeks. A complete blood count shows a hematocrit of 25%, a white blood cell count of 17,000/mm3 with frequent blasts, and a platelet count of 46,000/mm3. A bone marrow examination shows 40% myeloblasts. Fluorescence in situ hybridization shows monosomy 7 and 5q- in the majority of blasts. At the end of this course you should be able to:
- Identify those diagnostic tests that are necessary for allocating younger patients with AML to the most appropriate therapies.
- Discuss the possible induction therapies available as initial therapy for patients with AML.
- Define the categories of patients with AML for whom hematopoietic cell transplantation is an appropriate therapeutic option.
This activity was made available on 11/18/2015 and will be reviewed on an annual basis to determine continued availability. A maximum of 1 AMA PRA Category 1 Credit(s) ™ credit is available.
Medical Knowledge (ACGME, AAPA)
Health Promotion, Health Protection, Disease Prevention, and Treatment (ONS)
Note: This course is now accessible through mobile devices as well as personal computers